San Francisco-based Invuity, the company that helps surgeons better visualize what they do, has raised $13.2 million in new equity out of a financing deal that could be worth as much as $16 million, according to a regulatory filing. The document doesn’t say who invested, but Kleiner Perkins Caufield & Byers is a backer, according to the company’s website, and Kleiner partner Dana Mead Jr. is on the board, according to the filing.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
